HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Po-Ren Hsueh Selected Research

Ertapenem (Invanz)

6/2022Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
4/2022Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.
1/2020Antimicrobial susceptibilities of the ertapenem-non-susceptible non-carbapenemase-producing Enterobacterales isolates causing intra-abdominal infections in the Asia-Pacific region during 2008-2014: Results from the Study for Monitoring the Antimicrobial Resistance Trends (SMART).
1/2018Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
1/2016Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
4/2015Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
5/2013Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
6/2012Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
5/2011Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Po-Ren Hsueh Research Topics

Disease

128Infections
09/2022 - 01/2002
46Sepsis (Septicemia)
10/2022 - 02/2003
39Bacteremia
10/2018 - 09/2003
33Pneumonia (Pneumonitis)
10/2021 - 03/2004
27Tuberculosis (Tuberculoses)
01/2018 - 09/2004
23COVID-19
10/2021 - 01/2020
18Intraabdominal Infections
06/2022 - 07/2006
16Cross Infection (Nosocomial Infection)
04/2019 - 07/2002
15Neoplasms (Cancer)
12/2021 - 04/2006
13Urinary Tract Infections (Urinary Tract Infection)
03/2022 - 12/2007
11Shock
04/2020 - 07/2002
9Respiratory Tract Infections (Respiratory Tract Infection)
06/2022 - 09/2004
9Meningitis
04/2022 - 10/2005
9Endocarditis
11/2017 - 07/2002
9Fever (Fevers)
05/2013 - 04/2003
7Bacterial Infections (Bacterial Infection)
08/2018 - 04/2005
6Coinfection
04/2021 - 09/2003
6Thrombocytopenia (Thrombopenia)
01/2021 - 11/2005
6Severe Acute Respiratory Syndrome
01/2021 - 08/2004
6Chronic Kidney Failure (Chronic Renal Failure)
09/2018 - 08/2005
6Septic Shock (Toxic Shock Syndrome)
07/2018 - 03/2006
6Abscess
01/2018 - 01/2002
6Candidemia
12/2015 - 01/2002
6Peritonitis
06/2008 - 04/2003
5Pneumococcal Infections
04/2022 - 07/2006
5Latent Tuberculosis
04/2021 - 06/2009
4Community-Acquired Infections
01/2022 - 01/2006
4Acute Kidney Injury (Acute Renal Failure)
04/2020 - 01/2005
4Fungemia
01/2019 - 02/2005
4Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
03/2017 - 04/2013
4Empyema
01/2017 - 09/2006
4Multiple Organ Failure (MODS)
12/2015 - 09/2003
4Communicable Diseases (Infectious Diseases)
12/2015 - 11/2007
3Diarrhea
12/2021 - 03/2004

Drug/Important Bio-Agent (IBA)

56Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 04/2003
28Carbapenems (Carbapenem Antibiotics)IBA
10/2022 - 01/2005
20Pharmaceutical PreparationsIBA
01/2022 - 09/2004
18Tigecycline (Tygacil)FDA Link
03/2022 - 01/2005
18FluoroquinolonesIBA
04/2021 - 09/2007
18Anti-Infective Agents (Microbicides)IBA
04/2021 - 01/2002
17VancomycinFDA LinkGeneric
04/2022 - 07/2005
15EnzymesIBA
10/2011 - 09/2004
13Interferon-gamma (Interferon, gamma)IBA
01/2018 - 11/2006
12Linezolid (Zyvox)FDA Link
04/2022 - 04/2004
11beta-Lactamases (beta-Lactamase)IBA
06/2022 - 09/2003
10Rifampin (Rifampicin)FDA LinkGeneric
12/2021 - 09/2004
10InterferonsIBA
01/2020 - 10/2010
9Ertapenem (Invanz)FDA Link
06/2022 - 05/2011
9Penicillins (Penicillin)FDA Link
04/2022 - 02/2004
9SteroidsIBA
03/2021 - 11/2005
9Methicillin (Metin)FDA Link
07/2020 - 03/2008
9Ciprofloxacin (Cipro)FDA LinkGeneric
10/2017 - 01/2005
8carbapenemaseIBA
06/2022 - 01/2015
8ImipenemFDA Link
03/2022 - 10/2005
8Third Generation CephalosporinsIBA
01/2021 - 09/2004
8DaptomycinFDA Link
01/2016 - 07/2005
7Moxifloxacin (Avelox)FDA Link
04/2022 - 02/2012
7Ceftriaxone (Ceftriaxon)FDA LinkGeneric
04/2022 - 01/2002
7Levofloxacin (Levaquin)FDA Link
04/2022 - 03/2006
7Immunoglobulin G (IgG)IBA
10/2021 - 06/2004
7AntibodiesIBA
10/2021 - 07/2004
7Antifungal AgentsIBA
07/2014 - 01/2002
6MacrolidesIBA
12/2021 - 07/2003
6remdesivirIBA
10/2021 - 01/2020
6VaccinesIBA
01/2021 - 07/2006
6nemonoxacinIBA
12/2020 - 07/2009
6CytokinesIBA
01/2020 - 07/2002
6LactamsIBA
01/2019 - 10/2011
6DNA (Deoxyribonucleic Acid)IBA
11/2018 - 04/2003
6Fluconazole (Zonal)FDA LinkGeneric
05/2012 - 01/2002
5eravacyclineIBA
10/2022 - 01/2019
5ceftazidime drug combination avibactamIBA
09/2022 - 01/2018
5Immunoglobulin M (IgM)IBA
10/2021 - 06/2004
5Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2020 - 11/2008
5C-Reactive ProteinIBA
12/2015 - 12/2003
4Cefepime (Maxipime)FDA LinkGeneric
10/2022 - 02/2013
4QuinolonesIBA
04/2022 - 08/2009
4Caspofungin (Cancidas)FDA Link
06/2019 - 05/2006
4AminoglycosidesIBA
01/2019 - 10/2006
4Colistin (Coly-Mycin)FDA Link
09/2018 - 10/2011
4Cephalosporins (Cephalosporin Antibiotics)IBA
06/2016 - 01/2002
4Cefotaxime (Kendrick)FDA LinkGeneric
08/2015 - 10/2005
4Clindamycin (Cleocin)FDA LinkGeneric
08/2014 - 04/2005
4ProcalcitoninIBA
12/2011 - 03/2008
4AcidsIBA
10/2011 - 04/2005
4Isoniazid (Ftivazide)FDA LinkGeneric
09/2011 - 09/2004
4GlycopeptidesIBA
03/2008 - 04/2004
3omadacyclineIBA
10/2022 - 01/2021
3COVID-19 VaccinesIBA
04/2022 - 01/2021
3meropenem and vaborbactamIBA
03/2022 - 01/2019
3Tetracycline (Achromycin)FDA LinkGeneric
12/2021 - 10/2006

Therapy/Procedure

68Therapeutics
12/2021 - 01/2002
28Catheters
03/2018 - 02/2003
10Central Venous Catheters
12/2015 - 02/2003
6Drug Therapy (Chemotherapy)
04/2013 - 05/2005
5Long-Term Care
04/2021 - 01/2018
4Length of Stay
12/2021 - 04/2014
4Patient Care Bundles
08/2019 - 08/2013
4Renal Dialysis (Hemodialysis)
05/2016 - 06/2012
4Continuous Ambulatory Peritoneal Dialysis (CAPD)
05/2006 - 04/2003